The Union Health Ministry has amended the Drugs Rules, 1945 to tighten control over medicinal products that contain high concentrations of ethyl alcohol. Previously, certain aromatic preparations – such as cardamom and ginger tinctures – were exempted under Schedule K, allowing them to be sold without a licence. The new amendment removes this exemption, re‑classifying these products under Schedule H1 and mandating that any formulation with more than 12% v/v ethyl alcohol and a volume exceeding 30 ml must obtain a licence under the Drugs and Cosmetics Act, 1940.

Background and Existing Loopholes

Historically, many traditional and ayurvedic medicines containing alcohol were treated as “non‑controlled” because the alcohol was deemed a mere solvent. However, state‑level reports highlighted that some of these preparations contain up to 80‑90% ethyl alcohol, making them attractive for intoxication rather than therapeutic use. This misuse prompted the central government to revisit the regulatory framework.

Key Provisions of the Amendment

The amendment focuses on three core aspects:

• Licence Requirement: Any drug formulation exceeding the 12% v/v ethanol threshold must now be licensed, ensuring that manufacturers and distributors are vetted.
• Shift to Schedule H1: Inclusion in Schedule H1 obliges sellers to dispense the product only on a registered medical practitioner’s prescription and to maintain stricter inventory records.
• Supply‑Chain Traceability: The ministry extends QR‑code based traceability to vaccines, antimicrobials, and oncology drugs, creating a transparent digital trail across the pharmaceutical supply chain.

Implications for Public Health and Industry

By tightening controls, the government aims to significantly reduce the risk of diversion for recreational alcohol consumption while preserving legitimate therapeutic access. Industry observers note that this alignment with global best practices could improve India’s pharmaceutical credibility and encourage responsible innovation.

Expert Opinions

Pharmaceutical regulation analyst Dr. Anil Mehta remarked, “The amendment is a decisive step toward a rational drug‑use framework. It balances the need to prevent abuse with the necessity of keeping essential medicines available.” Public health scholars also view the move as part of a broader strategy to strengthen drug safety, promote responsible prescribing, and protect citizens from inadvertent alcohol exposure.